DBVT News and Press, DBV Technologies S.A. From 03/03/22

Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates m VP Pivotal Protocol Complete and Ready for Submission to FDA DBV Continues to E ngage in Productive Exchanges with FDA Cash ...

Gainers: Indonesia (NYSE:INDO) +60%. Tonix Pharmaceutical (NASDAQ:TNXP) +51%. Eos Energy Enterprises (NASDAQ:EOSE) +33%. Rimini Street (NASDAQ:RMNI) +30%. KLX Energy Services (NASDAQ:KLXE) +18%. DBV Technologies (NASDAQ:DBVT) +17%. Barrett Business Services (NASDAQ:BBSI) +16%. Ferroglobe (NAS...

Gainers: DBV Technologies (NASDAQ:DBVT) +16%. EyePoint Pharmaceuticals (NASDAQ:EYPT) +14%. Antares Pharma (NASDAQ:ATRS) +10%. Nuvalent (NASDAQ:NUVL) +8%. Aquestive Therapeutics (NASDAQ:AQST) +7%. Losers: NuCana (NASDAQ:NCNA) -54%. MediWound (NASDAQ:MDWD) -15%.&#x...

Indonesia Energy (NYSE:INDO) +46%. Imperial Petroleum (NASDAQ:IMPP) +20%. DBV Technologies (NASDAQ:DBVT) +19%. Canaan (NASDAQ:CAN) +18% on Q4 results. Cedar Realty (NYSE:CDR) +14% on acquisition by Wheeler REIT. Eos Energy (NASDAQ:EOSE) +14%. Wheeler Real Estate (NASDAQ:WH...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! In preparation for another busy day of trading, we’ve put together a list of the biggest pre-market stock movers for Thursday! Source: ventdusud / Shutterstock.com We’ve got ear...

DBV Technologies (NASDAQ:DBVT) is scheduled to announce FY earnings results on Thursday, March 3rd, after market close. The consensus EPS Estimate is -$0.48 (+83.7% Y/Y) and the consensus Revenue Estimate is $4.87M (-56.8% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisio...

ACR, AQN, AVAV, AVGO, BCEL, CEMI, CLLS, CLXT, COO, COST, OTCPK:CURLF, DBVT, DUOL, EGLE, ENVX, EOLS, ESTC, EVFM, FCRD, FDUS, FNKO, GPS, INMB, OTCPK:MEGEF, MRVL, NCMI, ONCY, PAYO, PBYI, SIGA, SWBI, VERI, VZIO For Seeking Alpha's full earnings season calendar, click here. For further details s...

Montrouge, France, February 24, 2022 DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmac...

Montrouge, France, February 22, 2022 DBV Technologies to Participate in Upcoming AAAAI 202 2 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced ...

Montrouge, France, February 14, 2022 DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conferenc e DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, ...